ArticlePloS one2019
Enhanced efficacy of sitravatinib in metastatic models of antiangiogenic therapy resistance.
Melissa Dolan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papertrialcites it
ArticlePloS one2019
Melissa Dolan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.